https://endotech.io/et-team/about-dr-anna-becker/
Dr. Anna Becker is the CEO and co-founder of EndoTech, a company that leverages artificial intelligence (AI) and machine learning for algorithmic trading in the financial markets. She earned her Ph.D. in AI from the Technion Institute of Technology and has over 20 years of experience working with investment algorithms. Dr. Becker has previously founded and sold several AI-centric FinTech companies, including Strategy Runner (EndoTech) (EndoTech).
Under her leadership, EndoTech has managed nearly a billion dollars in assets through advanced deep learning algorithms. These algorithms have been applied to manage institutional funds for over a decade, demonstrating both innovation and robustness in volatile markets like cryptocurrencies (EndoTech) (Dr. Anna Becker Bio).
Dr. Becker's work emphasizes risk mitigation in high-volatility environments, using AI to turn market volatility into investment opportunities. She is also committed to ethical AI practices and strives to make sophisticated trading tools accessible to a broader range of investors, not just institutional ones (Home of FinTech & Banking News).
For more information, you can visit her official biography or the EndoTech website.
Dr. Anna Becker - Profile
Profile:
Name: Dr. Anna Becker
Current Position: CEO & Co-Founder at EndoTech
Location: Greater Tel Aviv Area
Industry: Financial Technology (FinTech), Artificial Intelligence (AI)
Summary:
Visionary leader at the intersection of artificial intelligence and financial technology, Dr. Anna Becker is the CEO and co-founder of EndoTech. With a Ph.D. in AI from the esteemed Technion Institute of Technology, she brings over two decades of experience in developing and implementing investment algorithms. Her pioneering work in AI-driven trading strategies has positioned EndoTech at the forefront of the FinTech industry, managing nearly a billion dollars in assets through sophisticated deep learning algorithms.
Under her leadership, EndoTech has democratized access to advanced quantitative trading strategies, previously reserved for institutional investors, now available to private investors. Dr. Becker's expertise in risk mitigation and AI has been instrumental in navigating the volatility of financial markets, particularly in the cryptocurrency space.
Experience:
CEO & Co-Founder
EndoTech
January 2017 - Present
Founder & CEO
Strategy Runner
2005 - 2015
Director of Algo Class
Gilboa Fund
2000 - 2005
Education:
Ph.D. in Artificial Intelligence
Technion - Israel Institute of Technology
1995 - 2000
Skills:
Publications & Speaking Engagements:
Awards & Recognition:
Contact Information: